Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Orion Corporation patents

Patents where

Current Assignee

Name

Orion Corporation

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11352346 Process for the preparation of 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazole and the hydrogensulfate salt thereof	Patent 11352346 was granted and assigned to Orion Corporation on June, 2022 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	11352346	June 7, 2022
‌ US Patent 7267813 Inhalation particles incorporating a combination of two or more active ingredients	Patent 7267813 was granted and assigned to Orion Corporation on September, 2007 by the United States Patent and Trademark Office.		Orion Corporation	United States Patent and Trademark Office	7267813	September 11, 2007
‌ US Patent 6886560 Moisture protected powder inhaler	Patent 6886560 was granted and assigned to Orion Corporation on May, 2005 by the United States Patent and Trademark Office.		Orion Corporation	United States Patent and Trademark Office	6886560	May 3, 2005
‌ US Patent 7368607 Toremifene crystallization method	Patent 7368607 was granted and assigned to Orion Corporation on May, 2008 by the United States Patent and Trademark Office.		Orion Corporation	United States Patent and Trademark Office	7368607	May 6, 2008
‌ US Patent 10118933 Androgen receptor modulating compounds	Patent 10118933 was granted and assigned to Orion Corporation on November, 2018 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	10118933	November 6, 2018
‌ US Patent 11433021 Palonosetron for the treatment or prevention of nausea and vomiting	Patent 11433021 was granted and assigned to Orion Corporation on September, 2022 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	11433021	September 6, 2022
‌ US Patent 7172752 Combination particles for the treatment of asthma	Patent 7172752 was granted and assigned to Orion Corporation on February, 2007 by the United States Patent and Trademark Office.		Orion Corporation	United States Patent and Trademark Office	7172752	February 6, 2007
‌ US Patent D963485 Packaging	Patent D963485 was granted and assigned to Orion Corporation on September, 2022 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	D963485	September 13, 2022
‌ US Patent 11332460 Process for the preparation of a sulfonamide structured kinase inhibitor	Patent 11332460 was granted and assigned to Orion Corporation on May, 2022 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	11332460	May 17, 2022
‌ US Patent D986407 Inhaler	Patent D986407 was granted and assigned to Orion Corporation on May, 2023 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	D986407	May 16, 2023
‌ US Patent D976697 Packaging box	Patent D976697 was granted and assigned to Orion Corporation on January, 2023 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	D976697	January 31, 2023
‌ US Patent D960349 Inhaler	Patent D960349 was granted and assigned to Orion Corporation on August, 2022 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	D960349	August 9, 2022
‌ US Patent D982735 Inhaler	Patent D982735 was granted and assigned to Orion Corporation on April, 2023 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	D982735	April 4, 2023
‌ US Patent 8921378 Androgen receptor modulating carboxamides	Patent 8921378 was granted and assigned to Orion Corporation on December, 2014 by the United States Patent and Trademark Office.		Orion Corporation	United States Patent and Trademark Office	8921378	December 30, 2014
‌ US Patent D977627 Inhaler		Orion Corporation	Orion Corporation	United States Patent and Trademark Office	D977627	February 7, 2023
‌ US Patent 10336697 Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors	Patent 10336697 was granted and assigned to Orion Corporation on July, 2019 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	10336697	July 2, 2019
‌ US Patent 9657003 Androgen receptor modulating compounds	Patent 9657003 was granted and assigned to Orion Corporation on May, 2017 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	9657003	May 23, 2017
‌ US Patent 9458128 Catechol O-methyltransferase activity inhibiting compounds	Patent 9458128 was granted and assigned to Orion Corporation on October, 2016 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	9458128	October 4, 2016
‌ US Patent 9890139 CYP17 inhibitors/antiandrogens	Patent 9890139 was granted and assigned to Orion Corporation on February, 2018 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	9890139	February 13, 2018
‌ US Patent 11098032 Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors	Patent 11098032 was granted and assigned to Orion Corporation on August, 2021 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	11098032	August 24, 2021
‌ US Patent 8697723 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases	Patent 8697723 was granted and assigned to Orion Corporation on April, 2014 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	8697723	April 15, 2014
‌ US Patent 9249127 Alpha2 adrenoceptor agonists	Patent 9249127 was granted and assigned to Orion Corporation on February, 2016 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	9249127	February 2, 2016
‌ US Patent 10391082 Protein kinase inhibitors	Patent 10391082 was granted and assigned to Orion Corporation on August, 2019 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	10391082	August 27, 2019
‌ US Patent 10077259 Bicyclic heterocyclic derivatives as bromodomain inhibitors	Patent 10077259 was granted and assigned to Orion Corporation on September, 2018 by the United States Patent and Trademark Office.	Orion Corporation	Orion Corporation	United States Patent and Trademark Office	10077259	September 18, 2018
‌ US Patent 7425568 Compounds, which are potent inhibitors of Na	Patent 7425568 was granted and assigned to Orion Corporation on September, 2008 by the United States Patent and Trademark Office.		Orion Corporation	United States Patent and Trademark Office	7425568	September 16, 2008

Results per page:

84 results

0 selected

84 results

0 selected